CID-0-RAB Tablet by Dr Precision is a potent fixed-dose combination of Rabeprazole Sodium 20 mg and Domperidone 30 mg, expertly formulated to combat acid reflux, gastroesophageal reflux disease (GERD), and related upper gastrointestinal disorders. Rabeprazole Sodium, a proton pump inhibitor (PPI), effectively inhibits gastric acid secretion within hours by blocking the H+/K+ ATPase enzyme system in the stomach lining, providing sustained relief from heartburn, acid regurgitation, and epigastric discomfort. Complementing this, Domperidone, a dopamine D2 receptor antagonist and prokinetic agent, enhances gastric motility by increasing gastric contractions, thus accelerating gastric emptying and preventing nausea and vomiting commonly associated with delayed gastrointestinal transit. Manufactured under GMP-compliant conditions by BluepillExpress under the trusted Dr Precision label, CID-0-RAB offers a synergistic therapeutic effect, targeting both excessive acid production and impaired gastric emptying. This makes CID-0-RAB especially effective for patients with refractory GERD, non-ulcer dyspepsia, gastritis with motility issues, and nausea resulting from gastrointestinal dysfunction or medication side effects. The formulation ensures rapid onset of action with long-lasting benefits, improving patient comfort by reducing symptoms like bloating, post-meal fullness, and nausea while promoting ulcer healing and upper GI symptom management. CID-0-RAB is an essential solution for healthcare professionals seeking an advanced, multi-targeted approach to managing complex acid-related and motility gastrointestinal disorders.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Rabeprazole Sodium 20 mg and Domperidone 30 mg |
| Mechanism of Action | Rabeprazole inhibits gastric acid secretion; Domperidone enhances gastrointestinal motility |
| Indications | GERD, acid reflux, peptic ulcers, functional dyspepsia, nausea, gastritis with motility dysfunction |
| Onset of Action | Rabeprazole acts within 1 hour, maximum effect at 2-4 hours |
| Duration of Effect | Prolonged acid suppression and continued prokinetic benefit |
| Manufacturer | BluepillExpress under Dr Precision label |
| Quality Standards | GMP-compliant, precision formulation |
| Therapeutic Benefits | Fast relief of heartburn, bloating, indigestion, nausea, and improved gastric emptying |
| Combination Advantage | Targets both acid secretion and delayed gastric emptying for comprehensive symptom control |
| Attributes | Description |
|---|---|
| Formulation Type | Oral tablet |
| Dosage Strength | Rabeprazole 20 mg + Domperidone 30 mg per tablet |
| Therapeutic Class | Proton pump inhibitor and prokinetic agent combination |
| Packaging | Blister packs or bottles (pack size varies based on order) |
| Pharmacological Action | Acid suppression and enhanced gastric motility |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Shelf Life | Typically 2 years from manufacturing date |
| Compliance | Manufactured under GMP guidelines ensuring quality and safety |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
CID-0-RAB combines Rabeprazole’s potent acid suppression with Domperidone’s prokinetic action, targeting both excess stomach acid and delayed gastric emptying simultaneously, resulting in faster and more sustained relief of symptoms like heartburn and nausea.
Yes, CID-0-RAB’s dual mechanism addresses both acid secretion and gastric motility dysfunction, making it an effective treatment option for refractory GERD or patients whose symptoms persist despite single-agent treatment.
CID-0-RAB is manufactured under stringent GMP-compliant conditions by BluepillExpress under the Dr Precision label, ensuring precision formulation and consistent quality.
Domperidone acts on dopamine D2 receptors by antagonizing them in the chemoreceptor trigger zone and enhances gastric motility, which accelerates gastric emptying and prevents the sensation of nausea and vomiting.
CID-0-RAB is indicated for managing GERD, peptic ulcers, functional dyspepsia, gastritis with motility dysfunction, acid peptic disease, and nausea-vomiting related to delayed gastric emptying or medication use.
Country Of Origin: India
CID-0-RAB Tablet is a combination of Rabeprazole Sodium 20 mg and Domperidone 30 mg, used to treat acid reflux, gastroesophageal reflux disease (GERD), and other digestive disorders associated with excessive stomach acid and delayed gastric emptying. Rabeprazole acts as a proton pump inhibitor (PPI), while Domperidone is a prokinetic agent that enhances gastrointestinal motility. Together, they offer fast and long-lasting relief from heartburn, bloating, indigestion, and nausea. Manufactured under stringent quality norms by BluepillExpress, CID-0-RAB ensures effective acid suppression and upper GI symptom management.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
CID-0-RAB Tablet is a highly effective gastroprokinetic and acid suppression therapy that combines the benefits of Rabeprazole Sodium (20 mg) and Domperidone (30 mg). This dual-action medication is used in the treatment of gastric acid-related disorders, including GERD (Gastroesophageal Reflux Disease), peptic ulcers, acid reflux, indigestion, gastritis, functional dyspepsia, and nausea-vomiting associated with gastrointestinal dysfunction.
Rabeprazole Sodium is a proton pump inhibitor (PPI) that blocks the H+/K+ ATPase enzyme system in gastric parietal cells, effectively reducing the secretion of hydrochloric acid in the stomach. It provides long-lasting acid suppression, enabling ulcer healing and relief from symptoms like heartburn, acid regurgitation, and epigastric pain. Rabeprazole begins its action within one hour of administration and achieves maximum effect within 2–4 hours, with a prolonged duration of action.
Domperidone, on the other hand, is a dopamine D2 receptor antagonist that acts on the chemoreceptor trigger zone (CTZ) and enhances gastrointestinal motility by increasing the tone and amplitude of gastric contractions. It helps in the faster movement of food from the stomach to the intestine and prevents nausea and vomiting. It is particularly effective in managing gastroparesis, bloating, post-meal fullness, and nausea associated with acid disorders or medication use.
The synergistic combination of Rabeprazole and Domperidone in CID-0-RAB provides symptomatic relief from upper GI tract disorders, addresses the root cause (excess acid production), and improves gastric emptying. It is particularly helpful in patients who suffer from refractory GERD, non-ulcer dyspepsia, or acid reflux due to delayed gastric clearance.
CID-0-RAB is commonly prescribed for the following indications:
Gastroesophageal Reflux Disease (GERD)
Non-ulcer dyspepsia
Acid peptic disease
Zollinger-Ellison Syndrome
Gastritis with upper GI motility dysfunction
Functional dyspepsia
Chronic heartburn
Nausea and vomiting induced by medications or delayed gastric emptying
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
